Related Experiment Videos
Artificial heart valve testing in goats.
Scandinavian Journal of Thoracic and Cardiovascular Surgery
|January 1, 1986
Summary
The modified Björk-Shiley monostrut valve shows promise for mitral valve replacement in goats, achieving long-term survival without anticoagulation. Further hemodynamic and explant studies are needed to confirm its clinical applicability.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
Background:
- Mitral valve replacement is a critical procedure.
- The Björk-Shiley monostrut valve is a prosthetic device used in cardiac surgery.
- Modified valve surfaces may improve biocompatibility and reduce complications.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of a modified Björk-Shiley monostrut valve in the mitral position.
- To assess the feasibility of mitral valve replacement without anticoagulation in a large animal model.
Main Methods:
- The modified Björk-Shiley monostrut valve was implanted in the mitral position in 72 goats.
- A meticulous surgical technique involving isolated sutures was employed in a beating heart under normothermia.
- Postoperative care involved free-range living on a farm.
Main Results:
- The study achieved consecutive long-term survival of goats up to one year post-implantation.
- No anticoagulation was required for the surviving animals.
- One goat successfully gave birth to two offspring six months after valve replacement, indicating good physiological tolerance.
Conclusions:
- The modified Björk-Shiley monostrut valve demonstrates successful short-term outcomes in mitral position in goats without anticoagulation.
- Further hemodynamic assessments and explant analyses are essential to determine the valve's broader clinical applicability.